139 related articles for article (PubMed ID: 27430923)
1. [Analysis of Koch phenomenon of Mycobacterium tuberculosis-infected guinea pigs vaccinated with recombinant tuberculosis vaccine AEC/BC02].
Lu JB; Cheng BW; Deng HQ; Su C; Shen XB; Du WX; Yang L; Wang GZ; Xu M
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jul; 39(7):524-8. PubMed ID: 27430923
[TBL] [Abstract][Full Text] [Related]
2. Recombinant tuberculosis vaccine AEC/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection.
Lu JB; Chen BW; Wang GZ; Fu LL; Shen XB; Su C; Du WX; Yang L; Xu M
J Microbiol Immunol Infect; 2015 Dec; 48(6):597-603. PubMed ID: 24863497
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Effect of Subunit Vaccine AEC/BC02 on
Lu J; Guo X; Wang C; Du W; Shen X; Su C; Wu Y; Xu M
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632581
[TBL] [Abstract][Full Text] [Related]
4. The Subunit AEC/BC02 Vaccine Combined with Antibiotics Provides Protection in
Guo X; Lu J; Li J; Du W; Shen X; Su C; Wu Y; Zhao A; Xu M
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560574
[TBL] [Abstract][Full Text] [Related]
5. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S
Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313
[TBL] [Abstract][Full Text] [Related]
6. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
Cafaro A; Piccaro G; Altavilla G; Gigantino V; Matarese G; Olivieri E; Ferrantelli F; Ensoli B; Palma C
BMC Infect Dis; 2016 Aug; 16(1):442. PubMed ID: 27549342
[TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.
Sakthi S; Palaniyandi K; Gupta UD; Gupta P; Narayanan S
Vaccine; 2016 Feb; 34(6):735-43. PubMed ID: 26768127
[TBL] [Abstract][Full Text] [Related]
11. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
Chen L; Xu M; Wang ZY; Chen BW; Du WX; Su C; Shen XB; Zhao AH; Dong N; Wang YJ; Wang GZ
FEMS Immunol Med Microbiol; 2010 Jun; 59(1):42-52. PubMed ID: 20298499
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and therapeutic effects of recombinant Ag85AB fusion protein vaccines in mice infected with Mycobacterium tuberculosis.
Liang Y; Zhang J; Yang Y; Bai X; Yu Q; Li N; Hou Y; Shi Y; Wang L; Wu X
Vaccine; 2017 Jul; 35(32):3995-4001. PubMed ID: 28625522
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
[TBL] [Abstract][Full Text] [Related]
14. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
15. The contribution of hydrogen peroxide resistance to virulence of Mycobacterium tuberculosis during the first six days after intravenous infection of normal and BCG-vaccinated guinea-pigs.
Jackett PS; Aber VR; Mitchison DA; Lowrie DB
Br J Exp Pathol; 1981 Feb; 62(1):34-40. PubMed ID: 6784743
[TBL] [Abstract][Full Text] [Related]
16. Non-specific protection against pulmonary Legionella pneumophila infection in guinea-pigs immunized and challenged with mycobacteria.
Gibson DH; Baskerville A; Ashworth LA; Fitzgeorge RB
Br J Exp Pathol; 1985 Jun; 66(3):333-44. PubMed ID: 3924087
[TBL] [Abstract][Full Text] [Related]
17. The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine.
Li H; Li R; Zhong S; Ren H; Zou Y; Chen X; Shi X; Wang M; Long H; Luo Y
Vaccine; 2006 Feb; 24(9):1315-23. PubMed ID: 16219397
[TBL] [Abstract][Full Text] [Related]
18. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
[TBL] [Abstract][Full Text] [Related]
19. [A guinea pig model of latent Mycobacterium tuberculosis H₃₇Rv infection].
Li YL; Chen BW; Xu M; Luo YA; Wang GZ; Shen XB; Su C
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):684-7. PubMed ID: 21092637
[TBL] [Abstract][Full Text] [Related]
20. [The immunological responses induced by Mycobacterium tuberculosis heat shock protein 16.3 and its synthetic peptide in mice].
Shi CH; Zhang TF; Zhu DS; Zhang H; Bai B; Zhao Y; Yue CL; Zhao L; Liu JL
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):603-7. PubMed ID: 19958680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
